Factors Associated with Recurrence of Ameloblastoma: A Scoping Review

被引:3
作者
Inthong, Pornnutcha [1 ]
Upalananda, Witsarut [2 ]
Saepoo, Jay [1 ,3 ,4 ]
机构
[1] Prince Songkla Univ, Fac Dent, Dept Oral Diagnost Sci, Sect Oral & Maxillofacial Pathol, Hat Yai, Songkhla, Thailand
[2] Prince Songkla Univ, Fac Dent, Dept Oral Diagnost Sci, Sect Oral & Maxillofacial Radiol, Hat Yai, Songkhla, Thailand
[3] Prince Songkla Univ, Fac Dent, Dept Oral Diagnost Sci, Sect Oral Med, Hat Yai, Songkhla, Thailand
[4] Kanjanavanich Rd, Hat Yai 90110, Songkhla, Thailand
关键词
Ameloblastoma; Odontogenic Tumors; Recurrence; Risk Factors; Scoping Review; UNICYSTIC AMELOBLASTOMA; FREE FIBULA; SEGMENTAL MANDIBULECTOMY; MAXILLARY AMELOBLASTOMA; SURGICAL-MANAGEMENT; FREE SURVIVAL; RISK-FACTORS; EXPRESSION; JAWS; RECONSTRUCTION;
D O I
10.1007/s12105-024-01686-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PurposeThis scoping review aimed to identify factors associated with the recurrence of ameloblastoma.MethodsSystematic searches were conducted in PubMed, Scopus, and EMBASE, based on the board research question: "What factors are related to the recurrence of ameloblastoma?". English-language observational studies addressing the risk and preventive factors associated with recurrent ameloblastoma were included and data were extracted.ResultsEighty-three retrospective observational studies met the inclusion criteria. The identified prognostic factors for recurrence included: (1) Tumor size/diameter/volume, (2) cortical bone perforation/ soft tissue invasion, (3) multilocular radiolucency, (4) impacted tooth-involving lesions, (5) root resorption, (6) WHO classification - conventional (solid/multicystic) ameloblastoma, (7) histological subtype - mural invasion of unicystic ameloblastoma, (8) conservative treatment modalities - simple enucleation, curettage, and marsupialization, and (9) non-extraction/preservation of involved teeth. No strong evidence linked immunohistochemical expression to recurrence. Interestingly, BRAF p.V600E remained controversial in terms of recurrence, despite being a frequent finding in ameloblastoma.ConclusionCertain clinical characteristics, radiographic findings, histological subtypes, and treatment choices of ameloblastoma can help identify patients at high risk of recurrence. Further prospective studies to evaluate the prognostic factor model and research on immunohistochemistry are required.
引用
收藏
页数:11
相关论文
共 93 条
[21]   Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience [J].
Dandriyal, Ramakant ;
Lal, Vishakha ;
Giri, Kolli Yada ;
Bavanthabettu, Niranjanaprasad Indra ;
Chaurasia, Archana ;
Pant, Swati .
JOURNAL OF MAXILLOFACIAL & ORAL SURGERY, 2022, 21 (02) :730-738
[22]   The importance of BRAF-V600E mutation to ameloblastoma metabolism [J].
Duarte-Andrade, Filipe Fideles ;
Barbosa Silva, Andre Myller ;
Vitorio, Jessica Gardone ;
Baptista Canuto, Gisele Andre ;
Santos Costa, Sara Ferreira ;
Diniz, Marina Goncalves ;
Fernandes, Ana Paula ;
de Toledo, Juliano Simoes ;
Andre, Leiliane Coelho ;
Gomes, Carolina Cavalieri ;
Gomez, Ricardo Santiago ;
Fonseca, Felipe Paiva .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2019, 48 (04) :307-314
[23]   Recurrent ameloblastoma following osseous reconstruction - A review of twenty years [J].
Eckardt, Andre M. ;
Kokemueller, Horst ;
Flemming, Peter ;
Schultze, Arndt .
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2009, 37 (01) :36-41
[24]   Ameloblastoma: current etiopathological concepts and management [J].
Effiom, O. A. ;
Ogundana, O. M. ;
Akinshipo, A. O. ;
Akintoye, S. O. .
ORAL DISEASES, 2018, 24 (03) :307-316
[25]  
Fomete B, 2022, West Afr J Med, V39, P350
[26]   Prognostic importance of FGF2 and FGFR1 expression for patients affected by ameloblastoma [J].
Fonseca, Felipe Paiva ;
Benites, Bernar Monteiro ;
Soares, Ciro Dantas ;
de Lima Morais, Thayna Melo ;
do Amaral-Silva, Gleyson Kleber ;
de Almeida, Oslei Paes ;
Soares, Fernando Augusto ;
Fregnani, Eduardo Rodrigues .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (04) :417-424
[27]   Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas [J].
Fregnani, E. R. ;
da Cruz Perez, D. E. ;
de Almeida, O. P. ;
Kowalski, L. P. ;
Soares, F. A. ;
Alves, F. de Abreu .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 39 (02) :145-149
[28]   BRAF-V600E expression correlates with ameloblastoma aggressiveness [J].
Fregnani, Eduardo R. ;
da Cruz Perez, Danyel E. ;
de Almeida, Oslei Paes ;
Fonseca, Felipe Paiva ;
Soares, Fernando A. ;
Castro-Junior, Gilberto ;
Alves, Fabio A. .
HISTOPATHOLOGY, 2017, 70 (03) :473-484
[29]   Association of clinicopathological factors and treatment modalities in the recurrence of ameloblastoma: Analysis of 624 cases [J].
Goh, Yet Ching ;
Siriwardena, Bogahawatte Samarakoon Mudiyanselage Samadarani ;
Tilakaratne, Wanninayake Mudiyanselage .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2021, 50 (09) :927-936
[30]   The landscape of genetic alterations in ameloblastomas relates to clinical features [J].
Gultekin, Sibel Elif ;
Aziz, Reem ;
Heydt, Carina ;
Senguven, Burcu ;
Zoller, Joachim ;
Safi, Ali Farid ;
Kreppel, Matthias ;
Buettner, Reinhard .
VIRCHOWS ARCHIV, 2018, 472 (05) :807-814